Related Experiment Video

Updated: May 9, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Customised, Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC)

Muhammad Furrukh1, Mansour Al-Moundhri, Khawaja F Zahid

  • 1Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman;

Sultan Qaboos University Medical Journal
|July 18, 2013
PubMed

Insights

Targeted therapy offers non-small-cell lung cancer patients with specific mutations survival outcomes equivalent to chemotherapy but without side effects. This marks a shift towards personalized lung cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Advanced stage non-small-cell lung carcinoma (NSCLC) treatment traditionally relied on chemotherapy.
  • Tumorigenesis involves complex cellular mechanisms that can be targeted for therapeutic intervention.
  • Understanding drug resistance is crucial for optimizing treatment efficacy.

Purpose of the Study:

  • To review the molecular basis of lung carcinogenesis and its implications for targeted therapy.
  • To discuss advances in understanding primary and secondary drug resistance mechanisms.
  • To highlight the role of prognostic and predictive biomarkers in personalized NSCLC treatment.

Main Methods:

  • Review of phase II and randomized phase III clinical trials conducted in Asia and Europe.
  • Analysis of cellular mechanisms underlying lung carcinogenesis.
  • Examination of molecular biology findings related to drug resistance.

Main Results:

  • Targeted therapy in NSCLC adenocarcinoma subtypes with specific mutations yields survival outcomes comparable to chemotherapy.
  • Patients receiving targeted therapy avoid the adverse side effects associated with chemotherapy.
  • Therapy optimization, moving away from a 'chemotherapy for all' approach, is a significant paradigm shift.

Conclusions:

  • Targeted therapy represents an effective and less toxic alternative to chemotherapy for specific NSCLC patient populations.
  • Advances in molecular biology and biomarker research are driving personalized treatment strategies in lung cancer.
  • Translational research is critical for improving patient outcomes in oncology.
Keywords:
Biological markersCarcinomaLung neoplasmNon-small-cell lungProtein kinase inhibitors, Bevacizumab, ErlotinibReceptor, Epidermal growth factorVascular endothelial growth factor

More Related Videos

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...